HCG 5000IU | Packaging: 5000 IU, Primary purpose: Support of the endocrine axis, Secondary purpose: Preservation of strength/mass during transitional phases

New

HCG 5000IU – support of the testosterone axis and PCT

HCG stimulates endogenous production of testosterone and is often used as part of maintenance or transition protocols (PCT/intermediate phases). The goal is to preserve strength, muscle tone, and motivation, while the body restores its own balance. A practical tool for a smoother return to a normal routine and steady training.

0 reviews • Write a review

€ 25.00

Ex Tax: € 25.00

Qty

Add to Cart

Buy Now Question?

Add to Wish List

Ask a Question about this Product

Shipping

Secure and safe worldwide delivery! If the product is on stock - average delivery time is 2-3 days in Eastern Europe, 3-7 days in Western Europe and 1-3 weeks world wide!

Improved storage formula

Improved storage formula - increased stability and extended shelf life!

Quality Control & Tests

High-quality product! All peptides branded MyPeptid are produced in 100% laboratory conditions and have purity above 98%. Our products are tested at JINOSHIK, Analiza Białek and other independent, established laboratories with high standards!

Tags: Support for the endocrine axis

Product information

This peptide "signals" the body to produce more hormones and to support the maturation of reproductive cells via a signal similar to natural hormonal pulses.

What is HCG 5000IU?

Glycoprotein hormone from the molecular class of gonadotropins, which activates the LH/CG receptor (LHCGR) and triggers cAMP/PKA-associated signaling in steroidogenic cells, is at the core of the biological effect of human chorionic gonadotropin; an overview of general characteristics: Wikipedia: Human chorionic gonadotropin. In practice, "5000 IU" denotes standardized biological activity, which is important in comparable experimental designs.

Mechanism of action

Binding to LHCGR (GPCR) increases intracellular cAMP and activates PKA, which enhances the expression/activity of enzymes for steroidogenesis and downstream transcriptional programs; this is described in regulatory summaries and product characteristics of hCG: EMA and FDA.

Clinical/preclinical data (available, but dependent on indication)

study name	population or experimental model	number of subjects or samples	duration	key observed outcomes
Regulatory data (product labeling summary)	Clinical use in reproductive protocols	Heterogeneous; cohort sizes are not uniformly reported in public summaries	Dose-dependent; short courses	Numerical endpoints vary by protocol; public regulatory pages summarize indications/risks without a unified table of N and effect

Note: publicly available regulatory pages are authoritative for mechanism/indications, but often do not provide unified numerical results in a single format; if specific numerical endpoints are required it is recommended to consult full clinical publications (PubMed) for the particular indication.

Context of scientific use and laboratory setting

Suitable for models of LHCGR signaling, steroidogenesis, cellular assays for cAMP/PKA response and as a reference standard by activity (IU) when validating bioassays. In clinical settings hCG appears in regulatory-described protocols, but this product is offered for research purposes only.

Pharmacokinetics (for experimental design)

As a glycoprotein with receptor-mediated action, effects depend on the route of administration and sampling time; for design, serial measurements of hormonal markers and downstream signaling reads are planned, aligned with the short-term dynamics after dosing (described in regulatory sources: FDA, EMA).

Purity and specification

HCG 5000IU from MyPeptid provides reliable conditions for laboratory research, as it is over 99% pure and intended for controlled B2B applications (cellular assays, method development, QC).

Formula: C1105H1770N318O336S26

For sale only for educational and research purposes (research-only); not intended for use in patients.